{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:29:30Z","timestamp":1791653370803,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T00:00:00Z","timestamp":1381276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"},{"start":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T00:00:00Z","timestamp":1381276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep02903","type":"journal-article","created":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T09:03:45Z","timestamp":1381309425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Impact of fatty acids on human UDP-glucuronosyltransferase 1A1 activity and its expression in neonatal hyperbilirubinemia"],"prefix":"10.1038","volume":"3","author":[{"given":"Ayako","family":"Shibuya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Tukey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,9]]},"reference":[{"key":"BFsrep02903_CR1","unstructured":"Dutton, G. J. Acceptor substrates of UDP glucuronosyltransferase and their assay., in Glucuronidation of Drugs and Other Compounds (Dutton, G. J. ed); pp 69\u201378, CRC Press, Boca Raton, FL (1980)."},{"key":"BFsrep02903_CR2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/01.fpc.0000173483.13689.56","volume":"15","author":"PI Mackenzie","year":"2005","unstructured":"Mackenzie, P. I., Bock, K. W., Burchell, B., Guillemette, C., Ikushiro, S. & Iyanagi, T. et al. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics. 15, 677\u2013685 (2005).","journal-title":"Pharmacogenet Genomics."},{"key":"BFsrep02903_CR3","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1016\/S0021-9258(19)50724-4","volume":"267","author":"JK Ritter","year":"1992","unstructured":"Ritter, J. K., Chen, F., Sheen, Y. Y., Tran, H. M., Kimura, S. Yeatman, M. T. et al. A novel complex locus UGT1 encodes human bilirubin, phenol and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem. 267, 3257\u201361 (1992).","journal-title":"J Biol Chem."},{"key":"BFsrep02903_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1146\/annurev.pharmtox.40.1.581","volume":"40","author":"RH Tukey","year":"2000","unstructured":"Tukey, R. H. & Strassburg, C. P. Human UDP-glucuronosyltransferases: metabolism, expression and disease. Annu Rev Pharmacol Toxicol. 40, 581\u2013616 (2000).","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"BFsrep02903_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1081\/DMR-120000653","volume":"33","author":"MB Fisher","year":"2001","unstructured":"Fisher, M. B., Paine, M. F., Strelevitz, T. J. & Wrighton, S. A. The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metab Rev. 33, 273\u201397 (2001).","journal-title":"Drug Metab Rev."},{"key":"BFsrep02903_CR6","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1016\/S0021-9258(17)32403-1","volume":"269","author":"PJ Bosma","year":"1994","unstructured":"Bosma, P. J., Seppen, J., Goldhoorn, B., Bakker, C., Oude Elferink, R. P. & Chowdhury, J. R. Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem. 269, 17960\u20134 (1994).","journal-title":"J Biol Chem."},{"key":"BFsrep02903_CR7","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1542\/peds.32.6.995","volume":"32","author":"AJ Newman","year":"1963","unstructured":"Newman, A. J. & Gross, S. Hyperbilirubinemia in breast-fed infants. Pediatrics. 32, 995\u20131001 (1963).","journal-title":"Pediatrics."},{"key":"BFsrep02903_CR8","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1172\/JCI105078","volume":"43","author":"IM Arias","year":"1964","unstructured":"Arias, I. M., Gartner, L. M. Seifter, S. et al. Prolonged neonatal unconjugated hyperbilirubinemia associated with breast feeding and a steriod, pregnane-3(alpha), 20(beta)-diol, in maternal milk that inhibits glucuronide formation in vitro. J Clin Invest. 43, 2037\u20132047 (1964).","journal-title":"J Clin Invest."},{"key":"BFsrep02903_CR9","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1001\/jama.1986.03370230076034","volume":"255","author":"AP Schneider","year":"1986","unstructured":"Schneider, A. P. Breast milk jaundice in the newborn. A real entity. JAMA. 255, 3270\u20133274 (1986).","journal-title":"JAMA."},{"key":"BFsrep02903_CR10","first-page":"913","volume":"42","author":"IM Arias","year":"1963","unstructured":"Arias, I. M., Gartner, L. M., Seifter, S. & Furman, M. Neonatal unconjugated hyperbilirubinemia associated with breast feeding and a factor in milk that inhibits glucuronide formation in vitro. J Clin Invest. 42, 913 (1963).","journal-title":"J Clin Invest."},{"key":"BFsrep02903_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1203\/PDR.0b013e31822f242e","volume":"70","author":"Y Ota","year":"2011","unstructured":"Ota, Y., Maruo, Y., Matsui, K., Mimura, Y., Sato, H. & Takeuchi, Y. Inhibitory effect of 5\u00e2-pregnane-3\u00e1,20\u00e2-diol on transcriptional activity and enzyme activity of human bilirubin UDP-glucuronosyltransferase. Pediatr Res. 70, 453\u20137 (2011).","journal-title":"Pediatr Res."},{"key":"BFsrep02903_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0009-8981(72)90501-3","volume":"41","author":"BR Bevan","year":"1972","unstructured":"Bevan, B. R. & Holton, J. B. Inhibition of bilirubin conjugation in rat liver slices by free fatty acids, with relevance to the problem of breast milk jaundice. Clin Chim Acta. 41, 101\u20137 (1972).","journal-title":"Clin Chim Acta."},{"key":"BFsrep02903_CR13","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/adc.48.6.446","volume":"48","author":"T Hargreaves","year":"1973","unstructured":"Hargreaves, T. Effect of fatty acids on bilirubin conjugation. Arch Dis Child. 48, 446\u201350 (1973).","journal-title":"Arch Dis Child."},{"key":"BFsrep02903_CR14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0026-895X(25)09902-X","volume":"45","author":"M Pritchard","year":"1994","unstructured":"Pritchard, M., Fournel-Gigleux, S., Siest, G., Mackenzie, P. & Magdalou, J. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyses the glucuronidation of morphine, phenols and carboxylic acids. Mol Pharmacol. 45, 42\u201350 (1994).","journal-title":"Mol Pharmacol."},{"key":"BFsrep02903_CR15","first-page":"1389","volume":"25","author":"MD Green","year":"1997","unstructured":"Green, M. D., Belanger, G., Hum, D. W., Belanger, A. & Tephly, T. R. Glucur-onidation of opioids carboxylic acid-containing drugs and hydroxylated xenobiotics catalysed by expressed monkey UDP-glucuronosyltransfer-ase 2B9 protein. Drug Metab Dispos. 25, 1389\u201394 (1997).","journal-title":"Drug Metab Dispos."},{"key":"BFsrep02903_CR16","first-page":"507","volume":"26","author":"MD Green","year":"1998","unstructured":"Green, M. D., King, C. D., Mojarrabi, B., Mackenzie, P. I. & Tephly, T. R. Glucuronidation of amines and other xenobiotics catalysed by ex-pressed human UDP-glucuronosyltransferase 1A3. Drug Metab Dispos. 26, 507\u201312 (1998).","journal-title":"Drug Metab Dispos."},{"key":"BFsrep02903_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1006\/abbi.2000.1933","volume":"380","author":"AR Jude","year":"2000","unstructured":"Jude, A. R., Little, J. M., Freeman, J. P., Evans, J. E., Radominska-Pandya, A. & Grant, D. F. Linoleic acid diols are novel substrates for human UDP-glucuronosyltransferases. Arch Biochem Biophys. 380, 294\u2013302 (2000).","journal-title":"Arch Biochem Biophys."},{"key":"BFsrep02903_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1006\/abbi.2001.2344","volume":"389","author":"AR Jude","year":"2001","unstructured":"Jude, A. R., Little, J. M., Czernik, P. J., Tephly, T. R., Grant, D. F. & Radominska-Pandya, A. Glucuronidation of linoleic acid diols by human micro-somal and recombinant UDP-glucuronosyltransferases: identification of UGT2B7 as the major isoform involved. Arch Biochem Biophys. 389, 176\u201386 (2001).","journal-title":"Arch Biochem Biophys."},{"key":"BFsrep02903_CR19","first-page":"625","volume":"29","author":"AR Jude","year":"2001","unstructured":"Jude, A. R., Little, J. M., Bull, A. W., Podgorski, I. & Radominska-Pandya, A. 13-Hydroxy- and 13-oxooctadecadienoic acids: novel substrates for human UDP-glucuronosyltransferases. Drug Metab Dispos. 29, 625\u201355 (2001).","journal-title":"Drug Metab Dispos."},{"key":"BFsrep02903_CR20","first-page":"194","volume":"34","author":"J Sonka","year":"2001","unstructured":"Sonka, J., Little, J., Samokyszyn, V. & Radominska-Pandya, A. Glucuroni-dation of arachidonic acid, 20-hydroxy-eicosatetraenoic acid and prostaglandin E2 by human hepatic and intestinal UDP-glucuronosyl-transferases and recombinant UGT2B7. Drug Metab Rev. 34(Suppl 1): 194 (2001).","journal-title":"Drug Metab Rev."},{"key":"BFsrep02903_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.bcp.2003.08.025","volume":"67","author":"P Tsoutsikos","year":"2004","unstructured":"Tsoutsikos, P., Miners, J. O., Stapleton, A., Thomas, A., Sallustio, B. C. & Knights, K. M. Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7. Biochem Pharmacol. 67, 191\u20139 (2004).","journal-title":"Biochem Pharmacol."},{"key":"BFsrep02903_CR22","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1124\/dmd.108.021105","volume":"36","author":"A Rowland","year":"2008","unstructured":"Rowland, A., Knights, K. M., Mackenzie, P. I. & Miners, J. O. The \u201calbumin effect\u201d and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities. Drug Metab Dispos. 36, 1056\u201362 (2008).","journal-title":"Drug Metab Dispos."},{"key":"BFsrep02903_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1053\/j.gastro.2011.09.045","volume":"142","author":"R Fujiwara","year":"2012","unstructured":"Fujiwara, R., Chen, S., Karin, M. & Tukey, R. H. Reduced expression of UGT1A1 in intestines of humanized UGT1 mice via inactivation of NF-kB leads to hyperbilirubinemia. Gastroenterology. 142, 109\u201318 (2012).","journal-title":"Gastroenterology."},{"key":"BFsrep02903_CR24","doi-asserted-by":"publisher","first-page":"5024","DOI":"10.1073\/pnas.0913290107","volume":"107","author":"R Fujiwara","year":"2010","unstructured":"Fujiwara, R., Nguyen, N., Chen, S. & Tukey, R. H. Developmental hyperbilirubinemia and CNS toxicity in mice humanized with the UDP glucuronosyltransferase 1 (UGT1) locus. Proc Natl Acad Sci U S A. 107, 5024\u20139 (2010).","journal-title":"Proc Natl Acad Sci U S A."},{"key":"BFsrep02903_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/ajcn\/34.2.252","volume":"34","author":"RA Gibson","year":"1981","unstructured":"Gibson, R. A. & Kneebone, G. M. Fatty acid composition of human colostrum and mature breast milk. Am J Clin Nutr. 34, 252\u20137 (1981).","journal-title":"Am J Clin Nutr."},{"key":"BFsrep02903_CR26","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1124\/dmd.106.014191","volume":"35","author":"R Fujiwara","year":"2007","unstructured":"Fujiwara, R., Nakajima, M., Yamanaka, H., Nakamura, A., Katoh, M. Ikushiro, S. et al. Effects of coexpression of UGT1A9 on enzymatic activities of human UGT1A isoforms. Drug Metab Dispos. 35, 747\u201357 (2007).","journal-title":"Drug Metab Dispos."},{"key":"BFsrep02903_CR27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2174\/1389200023336992","volume":"3","author":"JH Lin","year":"2002","unstructured":"Lin, J. H. & Wong, B. K. Complexities of glucuronidation affecting in vitro in vivo extrapolation. Curr Drug Metab. 3, 623\u201346 (2002).","journal-title":"Curr Drug Metab."},{"key":"BFsrep02903_CR28","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1124\/dmd.108.021428","volume":"36","author":"A Nakamura","year":"2008","unstructured":"Nakamura, A., Nakajima, M., Yamanaka, H., Fujiwara, R. & Yokoi, T. Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab Dispos. 36, 1461\u20134 (2008).","journal-title":"Drug Metab Dispos."},{"key":"BFsrep02903_CR29","first-page":"665","volume":"97","author":"C Duval","year":"2004","unstructured":"Duval, C., Fruchart, J. C. & Staels, B. PPAR alpha, fibrates, lipid metabolism and inflammation. Arch Mal Coeur Vaiss. 97, 665\u201372 (2004).","journal-title":"Arch Mal Coeur Vaiss."},{"key":"BFsrep02903_CR30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1124\/dmd.106.013243","volume":"35","author":"K Senekeo-Effenberger","year":"2007","unstructured":"Senekeo-Effenberger, K., Chen, S., Brace-Sinnokrak, E., Bonzo, J. A., Yueh, M. F. Argikar, U. et al. Expression of the human UGT1 locus in transgenic mice by 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (WY-14643) and implications on drug metabolism through peroxisome proliferator-activated receptor alpha activation. Drug Metab Dispos. 35, 419\u201327 (2007).","journal-title":"Drug Metab Dispos."},{"key":"BFsrep02903_CR31","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.pcl.2009.04.005","volume":"56","author":"JF Watchko","year":"2009","unstructured":"Watchko, J. F. Identification of neonates at risk for hazardous hyperbilirubinemia: emerging clinical insights. Pediatr Clin North Am. 56, 671\u201387 (2009).","journal-title":"Pediatr Clin North Am."},{"key":"BFsrep02903_CR32","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1124\/dmd.107.016402","volume":"35","author":"R Fujiwara","year":"2007","unstructured":"Fujiwara, R., Nakajima, M., Yamanaka, H., Katoh, M. & Yokoi, T. Interactions between human UGT1A1, UGT1A4 and UGT1A6 affect their enzymatic activities. Drug Metab Dispos. 35, 1781\u20137 (2007).","journal-title":"Drug Metab Dispos."},{"key":"BFsrep02903_CR33","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/ajcn\/41.4.787","volume":"41","author":"DA Finley","year":"1985","unstructured":"Finley, D. A., L\u00f6nnerdal, B., Dewey, K. G. & Grivetti, L. E. Breast milk composition: fat content and fatty acid composition in vegetarians and non-vegetarians. Am J Clin Nutr. 41, 787\u2013800 (1985).","journal-title":"Am J Clin Nutr."},{"key":"BFsrep02903_CR34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.plefa.2009.05.006","volume":"81","author":"CL Jensen","year":"2009","unstructured":"Jensen, C. L. & Lapillonne, A. Docosahexaenoic acid and lactation. Prostaglandins Leukot Essent Fatty Acids. 81, 175\u20138 (2009).","journal-title":"Prostaglandins Leukot Essent Fatty Acids."},{"key":"BFsrep02903_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","volume":"53","author":"J Berger","year":"2002","unstructured":"Berger, J. & Moller, D. E. The mechanisms of action of PPARs. Annu Rev Med. 53, 409\u201335 (2002).","journal-title":"Annu Rev Med."},{"key":"BFsrep02903_CR36","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1124\/dmd.108.022731","volume":"36","author":"K It\u00e4aho","year":"2008","unstructured":"It\u00e4aho, K., Mackenzie, P. I., Ikushiro, S., Miners, J. O. & Finel, M. The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases. Drug Metab Dispos. 36, 2307\u201315 (2008).","journal-title":"Drug Metab Dispos."},{"key":"BFsrep02903_CR37","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1124\/dmd.30.12.1462","volume":"30","author":"Y Watanabe","year":"2002","unstructured":"Watanabe, Y., Nakajima, M. & Yokoi, T. Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10. Drug Metab Dispos. 30, 1462\u20139 (2002).","journal-title":"Drug Metab Dispos."},{"key":"BFsrep02903_CR38","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1124\/dmd.104.000794","volume":"32","author":"JA Williams","year":"2004","unstructured":"Williams, J. A., Hyland, R., Jones, B. C., Smith, D. A., Hurst, S. Goosen, T. C. et al. Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi\/AUC) ratios. Drug Metab Dispos. 32, 1201\u20138 (2004).","journal-title":"Drug Metab Dispos."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep02903","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep02903.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep02903.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T16:20:39Z","timestamp":1746030039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep02903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,9]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,12,20]]}},"alternative-id":["BFsrep02903"],"URL":"https:\/\/doi.org\/10.1038\/srep02903","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,9]]},"assertion":[{"value":"25 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2903"}}